Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. 2012 Jul 3; 109(27): 10897–10902.
Published online 2012 Jun 18. doi:  10.1073/pnas.1118822109
PMCID: PMC3390842
Cell Biology

Stress- and Rho-activated ZO-1–associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival


A central component of the cellular stress response is p21WAF1/CIP1, which regulates cell proliferation, survival, and differentiation. Inflammation and cell stress often up-regulate p21 posttranscriptionally by regulatory mechanisms that are poorly understood. ZO-1–associated nucleic acid binding protein (ZONAB)/DbpA is a Y-box transcription factor that is regulated by components of intercellular junctions that are affected by cytokines and tissue damage. We therefore asked whether ZONAB activation is part of the cellular stress response. Here, we demonstrate that ZONAB promotes cell survival in response to proinflammatory, hyperosmotic, and cytotoxic stress and that stress-induced ZONAB activation involves the Rho regulator GEF-H1. Unexpectedly, stress-induced ZONAB activation does not stimulate ZONAB’s activity as a transcription factor but leads to the posttranscriptional up-regulation of p21 protein and mRNA. Up-regulation is mediated by ZONAB binding to specific sites in the 3′-untranslated region of the p21 mRNA, resulting in mRNA stabilization and enhanced translation. Binding of ZONAB to mRNA is activated by GEF-H1 via Rho stimulation and also mediates Ras-induced p21 expression. We thus identify a unique type of stress and Rho signaling activated pathway that drives mRNA stabilization and translation and links the cellular stress response to p21 expression and cell survival.

Keywords: epithelia, RhoGTPases, tight junction, necrosis, apoptosis

Cells developed regulatory pathways that are activated in response to proinflammatory challenges, adverse extracellular conditions, and cytotoxic stress to ensure cell survival and tissue integrity. These pathways regulate expression of genes encoding factors required to cope with stress conditions and involve transcription factors that stimulate the synthesis of mRNAs encoding proteins required for specific responses. However, expression of many crucial stress-induced genes is regulated posttranscriptionally by mechanisms that are not well understood.

A central regulator of cell proliferation and survival is p21WAF1/CIP1, a protein up-regulated in response to inflammation, stress, and cell cycle entry (1). Although originally identified as a cell cycle inhibitor, p21 has multiple activities that link it to the regulation of proliferation, transcription, DNA repair, and cell death (1, 2). Control of p21 mRNA stability and translation is important for the cellular stress response, but the regulatory pathways that control these processes are not well understood (3).

Rho GTPases are central components of multiple subcellular signaling pathways and are known to regulate gene expression at the transcriptional level (46). Rho signaling also inhibits transcription of p21 by suppressing its promoter (7, 8); however, p21 protein and mRNA are often up-regulated in response to stimuli that activate Rho, such as TNFα, growth factor-induced cell cycle entry, and, depending on the cellular context, Ras activation (3, 4, 9). Hence, mechanisms must exist that can counteract Rho-stimulated inhibition of transcription. Although crucial for the understanding of p21 regulation and cell physiology, the underlying molecular mechanisms to explain these contradictory observations are not known.

A transcription factor activated by Rho signaling is ZO-1–associated nucleic acid binding protein (ZONAB)/DbpA, a member of the Y-box family of multifunctional nucleic acid binding proteins (1013). ZONAB is activated in different types of cancers (1420); hence, it would be important to know whether and how ZONAB promotes cell survival in response to cytotoxic stress and proinflammatory signals because targeting such survival pathways offers therapeutic benefits.

In epithelial cells, ZONAB associates with tight junctions by binding to ZO-1, a negative regulator, and its transcriptional activity is stimulated by GEF-H1, a RhoA exchange factor (10, 11). The transcriptional activity of ZONAB is also suppressed by binding to activated RalA in the cytoplasm downstream of Ras activation (21). GEF-H1 is activated by different stimuli including TNFα, EGF receptor and Erk signaling, and mechanical and environmental stress (11, 2224). Although Y-box factors are multifunctional proteins that can bind RNA in vitro and have been proposed to function as general translational repressors (12, 13, 25), physiological relevance and targets of this mechanism are unclear. Whether and how GEF-H1, RhoA, and ZONAB regulate translation and mRNA stability is also not known.

Here, we identify a unique type of stress-activated pathway that consists of Rho-activated, sequence-specific ZONAB binding to p21 mRNA, resulting in mRNA stabilization and enhanced translational efficiency. This pathway is required for cell survival during stress and represents a unique type of Rho-activated mechanism.


Cell Survival During Proinflammatory Signaling and Stress Is Regulated by ZONAB and GEF-H1.

TNFα and cellular stress such as external mechanical forces and infections activate GEF-H1, a guanine nucleotide exchange factor that mediates RhoA activation, and that, in turn, stimulates the transcription factor ZONAB (11, 2224, 2628). Therefore, we asked whether ZONAB is activated by GEF-H1 during the cellular stress response and is thus required for cell survival during stress. As a model system, we first used renal epithelial Madin–Darby canine kidney (MDCK) cell lines that allow the selective shRNA-mediated depletion of ZONAB and GEF-H1 expression (29, 30) and then assessed cell death by LDH release as a measure of necrosis, caspase 3/7 activation as an indicator of apoptosis, and redox activity to monitor metabolic activity.

Fig. 1A shows that both proteins were effectively depleted in cell lines expressing respective shRNAs. Necrosis and apoptosis assays revealed that the proinflammatory cytokine TNFα, hyperosmotic, and taxol-induced cytotoxic stress selectively induced cell death in ZONAB and GEF-H1 depleted cells along with a decrease in metabolic activity of the cultures (Fig. 1 BD). Survival of nonstressed cells was not affected by depletion of either protein as reported (31). Experiments using transient transfection of siRNAs, targeting different sequences as an alternative strategy for ZONAB depletion, also enhanced cell death in response to stress (Fig. S1 AC). Transfection reagents are well-known to induce cell stress and death (32); consequently, transfection itself already led to an increase in cell death upon ZONAB depletion. ZONAB expression is thus required for survival of MDCK cells during stress.

Fig. 1.
Regulation of cell survival by ZONAB. (A) Depletion of ZONAB and GEF-H1 in MDCK cell lines expressing control or specific shRNAs under the control of a tetracycline-regulated promoter. (B–D) MDCK cells were treated as in A and were then incubated ...

We next analyzed the role of ZONAB in two human epithelial cell lines to determine whether the survival function of ZONAB extends beyond kidney cells, which need to be well adapted to cope with conditions causing hyperosmotic stress. Fig. S1 DF demonstrates that survival of human corneal epithelial (HCE) cells and the intestinal epithelial adenocarcinoma cell line Caco-2 cells was similarly comprised by ZONAB depletion, indicating that ZONAB mediates survival of cells form different epithelial tissues.

We next used GEF-H1 targeting siRNAs to test the role of ZONAB downstream of GEF-H1. In control cells, depletion of GEF-H1 using siRNAs also led to increased cell death upon TNFα treatment (Fig. S2 A and B). In cells overexpressing ZONAB, however, no significant increase was observed upon GEF-H1 depletion, suggesting that overexpression can counteract depletion of GEF-H1 (Fig. S2C).

TNFα and Stress Do Not Stimulate the Transcriptional Activity of ZONAB.

ZONAB is a Y-box transcription factor that is active in proliferating cells and stimulates expression of genes that promote proliferation such as cyclin D1 and PCNA (10, 29, 31). Activation of GEF-H1 in proliferating cells leads to the dissociation of ZONAB/GEF-H1 complexes (11). TNFα and hyperosmotic shock also reduced coimmunoprecipitation of GEF-H1 with ZONAB (Fig. S3). Hence, we tested whether stress induces the transcriptional activity of ZONAB by using a dual luciferase reporter assay, in which firefly luciferase expression is driven by a promoter with a ZONAB binding site, and the control renilla luciferase by a promoter that lacks such a site but is otherwise identical (21). To increase the sensitivity of the assay, cells were first serum-starved to reduce ZONAB activity and then stimulated with TNFα.

Fig. 1E shows that stimulation of cells with the cytokine for different periods of time did not lead to differences in luciferase expression, indicating that the transcriptional activity of ZONAB was not increased. When proliferating cells in which ZONAB is active were stressed, the transcriptional activity of ZONAB was attenuated (Fig. S4A). Similarly, transcription from a full-length cyclin D1 promoter, which is stimulated by ZONAB, was attenuated (Fig. S4B). Stress thus leads to a reduction in ZONAB’s transcriptional activity.

ZONAB is regulated by its subcellular localization. In proliferating cells, ZONAB is enriched in the nucleus and transcriptionally active and increased RalA activation or ZO-1 expression leads to cytoplasmic sequestration (21, 31). Indeed, TNFα also induced a redistribution of ZONAB from the nucleus to the cytoplasm (Fig. 1 F and G). The junctional staining for ZONAB was also reduced, and the staining was enriched in the perinuclear cytoplasm (Fig. S5).

These results thus indicate that the cell survival function of ZONAB does not rely on its transcription factor function but involves a cytosolic activity of the protein.

Induction of p21 Expression and Cell Survival.

A protein crucial for cell survival that is up-regulated during stress and proinflammatory signaling is p21, because it inhibits apoptosis by attenuating the activation of caspase-3 and blocks Ask-1 (1, 33, 34). p21 expression is regulated at different levels including posttranscriptonal mechanisms (3). Therefore, we tested whether induction of p21 by stress depends on ZONAB and GEF-H1. Fig. 2A shows that stimulation with TNFα led to a ZONAB and GEF-H1–dependent up-regulation of p21 protein. Similar observations were made when cells were stressed or stimulated with EGF, hyperosmotic shock, or taxol (Fig. 2B). Thus, p21 expression in response to different types of stress, as well as cytokine and growth factors, is regulated by ZONAB and GEF-H1.

Fig. 2.
Regulation of p21 expression and cell survival. (A) Control, ZONAB, or GEF-H1 depleted cells were serum starved for 20 h and were then stimulated by TNFα as indicated. Expression of p21 and α-tubulin was determined by immunoblotting total ...

If p21 is a functionally important target, depletion of p21 should affect cell survival. We hence depleted p21 by transfecting specific siRNAs (Fig. 2C) and then analyzed induction of necrosis and apoptosis (Fig. 2 D and E). If p21 was depleted in MDCK, HCE, and Caco-2 cells, stress induced cell death (Fig. 2 D and E).

Thus, p21 is a functionally important component of the cellular stress response in epithelial cells that is up-regulated in a ZONAB and GEF-H1–dependent manner. Because the relative extents of necrosis and apoptosis differed between ZONAB and p21 depletion and between different types of stress and cell lines, however, p21 is unlikely to be the only stress-induced ZONAB target.

Posttranscriptional Regulation of p21 Expression.

We next analyzed the molecular mechanism by which ZONAB induces the expression of p21 by determining the effect of ZONAB and its regulators on p21 protein and mRNA expression. We used previously established conditional MDCK cell lines that allow the down-regulation of ZO-1, a junction-associated inhibitor of ZONAB; the overexpression or down-regulation of GEF-H1, an activator of ZONAB; or depletion of ZONAB (Fig. 3A) (29, 30).

Fig. 3.
Posttranscriptional regulation of p21 expression. (A) Scheme showing the role of GEF-H1 and ZO-1 in the regulation of ZONAB and gene expression. (BD) The indicated MDCK cell lines were analyzed by immunoblotting (B and D) or RT-PCR (C). In D ...

ZONAB activation by either depletion of its inhibitor ZO-1 or expression of its activator GEF-H1 stimulated, whereas depletion of GEF-H1 or ZONAB itself reduced p21 protein and mRNA expression (Fig. 3 B and C). The relative expression levels remained the same even when transcription was attenuated with actinomycin D, suggesting that regulation of p21 expression by ZONAB is a posttranscriptional process (Fig. 3D). Expression was lost when translation was inhibited with cycloheximide, suggesting that the up-regulation is not due to an inhibition of degradation of p21 protein (Fig. S6A). Real-time PCR experiments further demonstrated that TNFα stimulation led to a ZONAB-dependent increase in p21 mRNA levels that remained stable even after prolonged inhibition of transcription, whereas ZONAB depletion resulted in a rapid drop in mRNA expression to levels observed in unstimulated cells (Fig. 3E).

Our data suggest that ZONAB mediates stabilization of p21 mRNA and posttranscriptonal up-regulation of p21 protein expression. These observations are in agreement with previous work suggesting that mRNA stabilization is important for the TNFα-induced p21 induction (9). Nevertheless, we also measured the effect of ZONAB on the p21 promoter itself by performing luciferase reporter assays with a construct containing 2.4 kB of the p21 promoter region (7). Fig. S6B shows that depletion of ZONAB did not affect the activity of the promoter, further supporting the conclusion that ZONAB does not regulate p21 on the transcriptional level. Finally, we made use of MDCK cells expressing the SH3 domain of ZO-1, a cytosolic construct that binds ZONAB, preventing its nuclear accumulation and, thereby, inhibits transcription (10, 31). Immunoblotting revealed that expression of the SH3 domain was sufficient to induce p21 (Fig. 3F), indicating that, in contrast to transcription, cytoplasmic retention of ZONAB does not inhibit p21 induction and ZONAB’s role in the posttranscriptional regulation of gene expression.

Stimulation of p21 mRNA/ZONAB Complexes.

Up-regulation of p21 mRNA requires ZONAB; hence, we tested whether the two molecules form complexes in response to ZONAB activation. We immunoprecipitated ZONAB complexes from extracts derived from MDCK cells with reduced or increased GEF-H1 and ZONAB expression. The presence of specific mRNAs in isolated immunocomplexes was then tested by reverse transcription PCR.

Fig. 4A shows that p21 mRNA was detected in ZONAB immunoprecipitates from control, but not ZONAB or GEF-H1–depleted cells. If ZONAB was stimulated by overexpression of GEF-H1, the association of p21 mRNA with ZONAB was enhanced. A control mRNA encoding GAPDH was not detected in the ZONAB precipitates. Thus, activated ZONAB forms complexes with p21 mRNA.

Fig. 4.
Binding of ZONAB to p21 mRNA. (A) The indicated cell lines were incubated as for the experiments in Fig. 3C. The cells were then extracted and precipitated with control or anti-ZONAB IgG beads. Total mRNAs were extracted from precipitates and samples ...

Y-box factors can bind nucleic acids in vitro by targeting sequences with central C(N)CAUC motifs in RNA (35). Sequence analysis revealed that all known human p21 transcripts have two such potential binding sites in their 3′-UTR (Fig. 4B). In electrophoretic mobility shift assays with fluorescently labeled RNA oligonucleotides, probes representing these sites bound to GST-ZONAB, but not GST, and both probes could quench binding if added in nonlabeled form to either of the two fluorescent probes as long as the central binding motif was not mutated by substitution, indicating that binding was specific (Fig. 4 C and D). Addition of antibodies against ZONAB resulted in a supershift, confirming the presence of ZONAB in the reconstituted complexes (Fig. 4D). ZONAB can thus bind single-stranded RNAs corresponding to specific regions of the p21 mRNA 3′-UTR.

We next constructed a chimeric reporter to determine the functional importance of the 3′-UTR and the ZONAB binding sites suggested by the in vitro binding studies. Addition of the entire 3′-UTR of human p21 mRNA to a luciferase cDNA resulted in an induction of luciferase expression in response to growth factors or TNFα (Fig. 4E). Full activity of the 3′-UTR was only achieved if both ZONAB binding sites were present but not if they were substituted (Fig. 4F), indicating that the p21-3′-UTR mediates induction of protein. Quantifications of luciferase protein and mRNA expression after TNFα treatment further demonstrated that the presence of ZONAB resulted in increased translational efficiency of the chimeric mRNA (Fig. 4G).

These experiments demonstrate that ZONAB activation leads to the formation of p21 mRNA/ZONAB complexes via specific binding sites in the 3′-UTR, leading to p21 mRNA stabilization and enhanced translation.

Stimulation of p21 Expression by Rho and Ras Signaling.

p21 protein and mRNA are up-regulated in response to many stimuli that also activate Rho, such as TNFα, and, depending on the cellular context, Ras activation; however, Rho signaling inhibits transcription of p21 (7, 8). For example, stimulation of cell cycle entry by Ras activation leads to Rho activation and increased expression of p21, which is required for efficient cell cycle progression (4). The mechanism that drives p21 up-regulation under these conditions is unknown.

Because ZONAB is activated by the Rho activator GEF-H1 and GEF-H1 stimulates p21 expression, we first tested whether GEF-H1 mediates p21 up-regulation via Rho and ZONAB. Fig. 5A shows that increased expression of p21 in response to GEF-H1 transfection required ZONAB because it was strongly reduced in ZONAB-depleted cells. Inhibition of Rho by C3 transferase suppressed p21 expression in control and GEF-H1 overexpressing cells to similar levels, indicating that GEF-H1 function is Rho dependent (Fig. 5B). GEF-H1 thus stimulates p21 expression via a Rho- and ZONAB-dependent mechanism.

Fig. 5.
Regulation of p21 expression by Rho and Ras signaling. (A) Control and ZONAB-depleted cells were transfected with increasing amounts of a plasmid encoding GEF-H1. Extracts were then immunoblotted as indicated. (B) Control or GEF-H1–overexpressing ...

TNFα is a strong inducer of Rho signaling and activates GEF-H1 via EGF receptor and Erk (11, 23, 24). EGF release in response to TNFα is mediated by TACE, a process that depends on p38 activation (24, 36). Phosphorylation of GEF-H1 in response to TNFα is also observed in MDCK cells (Fig. S7).

To test the role of MAP kinases and Rho activation, we first asked whether the regulatory activity of the 3′-UTR is regulated by Rho using the chimeric luciferase 3′-UTR construct. Fig. 5C shows that transfection of a constitutively active RhoA mutant stimulated the reporter. Moreover, TNFα and growth factor-induced luciferase expression were blocked by the Rho inhibitor C3 transferase (Fig. 5D). Inhibition of Erk with UO126 and, to a lesser extent, inhibition of p38 with SB203580 attenuated p21 protein expression in response to TNFα (Fig. S8 A and B); these inhibitors also blocked up-regulation of the chimeric luciferase mRNA by TNFα and growth factors (Fig. 5E). Induction of p21 expression by ZONAB overexpression was not affected by UO126, which is compatible with ZONAB functioning downstream of Erk (Fig. S8C). These data thus indicate that TNFα and growth factors regulate the activity of the 3′-UTR via Erk and Rho activation. Expression of constitutively active RhoA could counteract the effect of the MAP kinase inhibitors, suggesting that it functions downstream p38 and Erk (Fig. S9A). Moreover, overexpression of ZONAB stimulated luciferase expression in inhibitor treated cells, compatible with a role of the Y-box factor downstream of Erk and Rho activation (Fig. 5F). Blocking Erk activation also prevented complex formation by ZONAB and p21 mRNA, supporting the results with the reporter construct (Fig. S9B).

To test whether up-regulation of p21 by Ras is ZONAB dependent, we transfected MDCK cells with an active form of Ras, H-RasV12, and monitored the expression of p21. Expression of increasing amounts of active Ras led to increasing levels of p21 expression (Fig. S10A). However, if ZONAB was depleted, cells expressing H-RasV12 failed to up-regulate p21 (Fig. 5G). ZONAB is thus required for p21 induction stimulated by constitutively active Ras signaling. Unlike transcription, which is inhibited by Ras-stimulated Ral activation (21), the activity of the 3′-UTR reporter was not significantly affected by the expression of an inhibitor of Ral signaling (Fig. S10B). This observation suggests that, in contrast to transcription, the posttranscriptional activity of ZONAB is not inhibited by Ral signaling.


We have identified a cytosolic stress response pathway that mediates cell survival by inducing p21 expression in a Rho-dependent manner by mRNA stabilization and increased translational efficiency. In response to Rho activation, the Y-box factor ZONAB complexes with p21 mRNA by binding to specific sites in the 3′-UTR (Fig. 5H). This mechanism thus links specific mRNA stabilization and regulation of translational efficiency to the Rho signaling network.

p21 represents a functionally important ZONAB target that has been shown to affect apoptosis by regulating the activation of caspase-3 (33). It is intriguing that depletion of p21 can also lead to necrosis, suggesting that it does not only function as an inhibitor of apoptosis but plays a more general role in cell survival. However, the molecular mechanisms that control and mediate necrosis are still not well understood (37, 38). The extent of necrosis and apoptosis differed in different cell lines and in response to different types of stress, suggesting that the here-identified pathway cross-talks with other survival mechanisms and, as expected, is influenced by the metabolic state of the cells (37, 39). Despite the functional importance of p21, depletion of ZONAB induced necrosis and apoptosis more strongly than depletion of p21. It will thus be important to identify additional ZONAB targets to fully comprehend its role in cell survival.

Many of the stimulants that activate GEF-H1, such as TNFα, EGF, and mechanical stress, induce activation of Ras and Erk signaling (2224, 26), indicating that the GEF-H1/ZONAB pathway can be activated by multiple external stimuli. GEF-H1 is also activated by various pathogens, junction dissociation, and tissue disruption (28, 30, 40, 41). Moreover, ZONAB is stimulated by reduced expression of ZO-1, a cellular inhibitor of the transcriptional and posttranscriptional function of ZONAB, linking it to the integrity of tight junctions (10). ZONAB thus represents a stress-activated signaling mechanism that can receive signals from a range of stimuli, including growth factors, cytokines, pathogens, environmental stress, and oncogene-induced transformation that leads to tissue damage and dissociation of cell-cell adhesion.

Ras signaling plays an important role in the regulation of ZONAB (Fig. 5H). Ras activation inhibits ZONAB’s function as a transcription factor by inducing the formation of cytoplasmic complexes between activated RalA and ZONAB (21). RalA is activated by different types of stress and transmits cytokine-induced signals; hence, RalA activation seems to be a general mechanism to switch off the transcriptional activity of ZONAB (4245). However, Ral signaling does not affect ZONAB’s posttranscriptional activity. The second Ras-activated pathway that regulates ZONAB stimulates GEF-H1/RhoA signaling via Erk activation and can stimulate the transcriptional and the posttranscriptonal activity of ZONAB. The Erk/GEF-H1/RhoA axis thus reflects a general activation pathway, whereas RalA functions as a tuner that modulates the transcriptional function by cytoplasmic retention.

The here-identified mechanism of Rho-stimulated p21 expression also provides a molecular explanation for apparently contradictory observations. The p21 promoter is suppressed by Ras-activated Rho signaling, but p21 mRNA and protein are up-regulated by Ras signaling and cell cycle entry (4). Our data now show that ZONAB is activated by Ras signaling and promotes p21 expression posttranscriptionally even when transcription driven by the p21 promoter is reduced. Activation of Rho signaling thus leads to two opposed mechanisms that regulate p21 mRNA and protein expression: a pathway that reduces the activity of the p21 promoter and, thus, inhibits transcription and a ZONAB-dependent, posttranscriptional mechanism the leads to p21 mRNA stabilization and enhanced translation. Nevertheless, expression of oncogenic Ras and cell transformation also stimulates junction dissociation; hence, oncogenic Ras signaling stimulates ZONAB not only via RhoA.

Ras signaling is an important driver of tumorigenesis (4). The ZONAB-dependent survival pathway thus provides a possible therapeutic opportunity to target ZONAB to induce cell death in cancer cells. This survival pathway seems up-regulated in different types of carcinomas because ZONAB has been reported to be up-regulated in cancers form different tissues (1420). Therapeutic targeting of ZONAB might also improve the effectiveness of existing therapies, because depletion enhanced cell death in response to Taxol (Fig. 1).

From an evolutionary perspective, it is intriguing that mammalian Y-box factors, in which a cold shock domain mediates the interaction with nucleic acids, are linked to RNA binding in response to stress. Cold shock domain proteins have first been identified in bacteria as small proteins containing just the cold shock domain that bind RNAs in response to cold shock to prevent secondary structure formation (46). Hence, cold shock domain-containing proteins retained an evolutionarily conserved role in binding RNA during cellular stress to ensure RNA function and cell survival.

Materials and Methods

All cell lines were grown under standard conditions and transfected as described (11, 30, 31). Necrosis and apoptosis were analyzed by measuring LDH release and caspase 3/7 activity, respectively. A comprehensive description of all experimental procedures is included in SI Materials and Methods.

Supplementary Material

Supporting Information:


This research was supported by the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the Medical Research Council.


The authors declare no conflict of interest.

This article is a PNAS Direct Submission. K.B. is a guest editor invited by the Editorial Board.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1118822109/-/DCSupplemental.


1. Abbas T, Dutta A. p21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400–414. [PMC free article] [PubMed]
2. Dotto GP. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta. 2000;1471:M43–M56. [PubMed]
3. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal. 2010;22:1003–1012. [PMC free article] [PubMed]
4. Coleman ML, Marshall CJ, Olson MF. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol. 2004;5:355–366. [PubMed]
5. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans. 2005;33:891–895. [PubMed]
6. Braga VM, Yap AS. The challenges of abundance: Epithelial junctions and small GTPase signalling. Curr Opin Cell Biol. 2005;17:466–474. [PubMed]
7. Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature. 1998;394:295–299. [PubMed]
8. Adnane J, Bizouarn FA, Qian Y, Hamilton AD, Sebti SM. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: Involvement of the small GTPase rhoA. Mol Cell Biol. 1998;18:6962–6970. [PMC free article] [PubMed]
9. Shiohara M, Akashi M, Gombart AF, Yang R, Koeffler HP. Tumor necrosis factor alpha: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J Cell Physiol. 1996;166:568–576. [PubMed]
10. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 2000;19:2024–2033. [PMC free article] [PubMed]
11. Nie M, Aijaz S, Leefa Chong San IV, Balda MS, Matter K. The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Rep. 2009;10:1125–1131. [PMC free article] [PubMed]
12. Matsumoto K, Bay BH. Significance of the Y-box proteins in human cancers. J Mol Genet Med. 2005;1:11–17. [PMC free article] [PubMed]
13. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays. 2003;25:691–698. [PubMed]
14. Hayashi J, et al. Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis. Int J Oncol. 2002;21:847–850. [PubMed]
15. Yasen M, et al. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Clin Cancer Res. 2005;11:7354–7361. [PubMed]
16. Wang GR, et al. Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells. Acta Pharmacol Sin. 2009;30:1436–1442. [PMC free article] [PubMed]
17. Sharp JA, Mailer SL, Thomson PC, Lefèvre C, Nicholas KR. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line. Mol Cancer. 2008;7:1. [PMC free article] [PubMed]
18. Pannequin J, et al. Phosphatidylethanol accumulation promotes intestinal hyperplasia by inducing ZONAB-mediated cell density increase in response to chronic ethanol exposure. Mol Cancer Res. 2007;5:1147–1157. [PubMed]
19. Luedde T, Schwabe RF. NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:108–118. [PMC free article] [PubMed]
20. Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010;28:4045–4051. [PubMed]
21. Frankel P, et al. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J. 2005;24:54–62. [PMC free article] [PubMed]
22. Birkenfeld J, Nalbant P, Yoon SH, Bokoch GM. Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: Is altered GEF-H1 activity a crucial determinant of disease pathogenesis? Trends Cell Biol. 2008;18:210–219. [PubMed]
23. Kakiashvili E, et al. GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: Role in the regulation of tubular paracellular permeability. J Biol Chem. 2009;284:11454–11466. [PMC free article] [PubMed]
24. Kakiashvili E, et al. The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium. J Biol Chem. 2011;286:9268–9279. [PMC free article] [PubMed]
25. Sommerville J, Ladomery M. Masking of mRNA by Y-box proteins. FASEB J. 1996;10:435–443. [PubMed]
26. Guilluy C, et al. The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. Nat Cell Biol. 2011;13:722–727. [PMC free article] [PubMed]
27. Birukova AA, et al. Mechanotransduction by GEF-H1 as a novel mechanism of ventilator-induced vascular endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 2010;298:L837–L848. [PMC free article] [PubMed]
28. Matsuzawa T, Kuwae A, Yoshida S, Sasakawa C, Abe A. Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J. 2004;23:3570–3582. [PMC free article] [PubMed]
29. Sourisseau T, et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol. 2006;26:2387–2398. [PMC free article] [PubMed]
30. Aijaz S, D’Atri F, Citi S, Balda MS, Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell. 2005;8:777–786. [PubMed]
31. Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 2003;160:423–432. [PMC free article] [PubMed]
32. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry. 2004;43:13348–13356. [PubMed]
33. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: Activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998;17:931–939. [PubMed]
34. Asada M, et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 1999;18:1223–1234. [PMC free article] [PubMed]
35. Giorgini F, Davies HG, Braun RE. MSY2 and MSY4 bind a conserved sequence in the 3′ untranslated region of protamine 1 mRNA in vitro and in vivo. Mol Cell Biol. 2001;21:7010–7019. [PMC free article] [PubMed]
36. Xu P, Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell. 2010;37:551–566. [PMC free article] [PubMed]
37. Edinger AL, Thompson CB. Death by design: Apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004;16:663–669. [PubMed]
38. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263–268. [PMC free article] [PubMed]
39. Jin S, DiPaola RS, Mathew R, White E. Metabolic catastrophe as a means to cancer cell death. J Cell Sci. 2007;120:379–383. [PMC free article] [PubMed]
40. Samarin SN, Ivanov AI, Flatau G, Parkos CA, Nusrat A. Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell. 2007;18:3429–3439. [PMC free article] [PubMed]
41. Fukazawa A, et al. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog. 2008;4:e1000228. [PMC free article] [PubMed]
42. Jeon H, et al. Comparative analysis of the role of small G proteins in cell migration and cell death: Cytoprotective and promigratory effects of RalA. Exp Cell Res. 2011;317:2007–2018. [PubMed]
43. Hu Y, Mivechi NF. HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. J Biol Chem. 2003;278:17299–17306. [PubMed]
44. Fan S, Meng Q, Laterra JJ, Rosen EM. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene. 2007;26:4774–4796. [PubMed]
45. Sugihara K, et al. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat Cell Biol. 2002;4:73–78. [PubMed]
46. Horn G, Hofweber R, Kremer W, Kalbitzer HR. Structure and function of bacterial cold shock proteins. Cell Mol Life Sci. 2007;64:1457–1470. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene
    Gene links
  • Gene (nucleotide)
    Gene (nucleotide)
    Records in Gene identified from shared sequence links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene links
  • MedGen
    Related information in MedGen
  • Nucleotide
    Published Nucleotide sequences
  • Pathways + GO
    Pathways + GO
    Pathways, annotations and biological systems (BioSystems) that cite the current article.
  • Protein
    Published protein sequences
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...